You are at the kitchen table with a recertification note open on your laptop. The patient is a 71-year-old woman with metastatic breast cancer — spread to bone and liver — now in her second benefit period. You have known her for months. You can see, plainly, that she is weaker than she was at admission. At your first visits she met you at the front door. Today her daughter walked you back to the bedroom, because that is where she stays now. So you write what you see: “PPS 50%. Patient continues to decline. Remains appropriate for hospice.” It is true. You know it is true.
But if that note lands in front of a medical reviewer six months from now, it will not hold up — because the one person who cannot see this patient is the only person the note has to convince.
Performance Status Is the Spine of the Cancer Case
For most cancer diagnoses, the Palliative Performance Scale is the central functional marker in the LCD picture. The cancer guidelines generally look for a PPS of 60% or below, alongside findings like metastatic disease, continued decline despite — or in the absence of — disease-directed therapy, weight loss, declining albumin, or a rising burden of hospitalizations and symptoms. PPS is where the patient’s whole trajectory gets expressed in a single functional number.
And that is exactly where the documentation tends to fail. A PPS score written by itself is a conclusion, not evidence. “PPS 50%” is your professional judgment — but the reviewer cannot audit your judgment. They can only audit your observations. A conclusion is yours to draw. Evidence is what lets someone else, looking only at the page, draw the same conclusion you did at the bedside.
The Specificity Principle, Applied to PPS
Rather than treating PPS as a box to check, document where on the functional spectrum the patient actually falls — and which direction they are moving. Walk it with me.
PPS 60%
Reduced ambulation. The patient can no longer manage hobbies or housework, but still gets up and around with only occasional assistance. In cancer, an admission at 60% is usually reserved for an aggressive malignancy expected to decline quickly — the score is high, but the trajectory is steep.
PPS 50%
Mainly sitting or lying down, unable to do any work, requiring considerable assistance with personal care. Picture the patient in assisted living who can still be walked from her room to the dining hall twice a day with help — that is the full extent of her activity.
PPS 40%
Mainly in bed, needing assistance for nearly everything. Using the same patient: she now makes that walk to the dining hall only once a day, or has lost it entirely and can manage only five to ten feet to the bathroom with significant effort. That shift — from 50% to 40% — is a real, documentable decline. Capturing the specific functional change is what makes it defensible.
Two rules nurses miss most
First, there is no 45%. The scale moves in 10% increments, which is a problem in the first 90 days when a patient may not yet have dropped a full step. The solution is to document the trend within a score — “PPS remains 50% but ambulation has decreased from twice-daily dining-hall trips to once daily, with increasing fatigue; patient is trending toward 40%.” You are showing decline before the number formally moves.
Second, the PPS number must never stand alone. It has to be anchored to the specific observations that justify it — how far the patient can walk, how much help they need, how much they are eating, and how all of that compares to the last visit.
Same Patient, Two Notes
Here is the difference, side by side, for the same visit.
Weak: PPS 50%. Patient declining. Continues to be appropriate for hospice.
Defensible: PPS assessed at 50% — patient is now mainly sitting or lying, ambulates with assistance from bed to bedside chair and to the bathroom (approximately 10 feet) once or twice daily, and is no longer able to walk to the dining area as she did one month ago. Requires considerable assistance with bathing and dressing. Oral intake has dropped to roughly 25–30% of meals offered. Weight 140 lb at admission, 124 lb today — an 11% loss over five months — with no edema or fluid retention to account for it. This represents a decline from prior functional baseline; patient is trending toward PPS 40%.
Both notes describe a declining cancer patient. Only one proves it. The clinical reality is identical; the defensibility is not.
Eleanor: One Patient, Two Recertification Periods
Let me make this concrete with a hypothetical. Eleanor is 71, with metastatic breast cancer to bone and liver. She was admitted at PPS 60% — appropriate, because her disease is aggressive and her decline was expected to be rapid. At admission she was up and walking with a cane, doing light activity around the apartment, eating most of a meal.
By her first recertification, the picture has moved. She is at PPS 50%: mainly sitting and lying, walking only to the dining hall and back with her daughter’s arm, eating maybe half of what she did. Her weight is 132 lb, down from 140. Her most recent albumin is 3.3, down from 3.6 — a sign her body is no longer building protein, and a finding that supports the nutritional-decline picture. She has had one emergency visit for uncontrolled bone pain.
By her second recertification, the trajectory continues. She is now at PPS 40%: mainly in bed, able to manage only the few feet to the bathroom with two-person assist, declining the dining hall entirely. Intake is down to roughly a quarter of meals. Weight is 124 lb — now an 11% loss over the six-month window, and critically, with no edema present to mask it. Albumin has fallen to 3.1. There has been a second ER visit and early difficulty swallowing thin liquids.
Notice what the chart now shows. It is not a single snapshot of a sick patient — it is a documented arc of decline from 60% to 50% to 40%, with weight, albumin, intake, ambulation, and acute events all moving in the same direction. A reviewer reading those three notes does not have to take anyone’s word that Eleanor is dying. The page shows it.
One caution that travels with this case: if Eleanor had developed ascites or lower-extremity edema — common when liver involvement and low albumin combine — her weight on the scale might have held steady or even risen, masking real lean-body-mass loss. When albumin drops, fluid leaks out of the blood vessels and pools in the tissues. The scale can lie. Document weight and fluid status separately, and note when weight stability is attributable to fluid retention rather than true nutritional stability.
Five Questions Before You Finalize a Cancer Recert Note
- Did I write a PPS number — and did I anchor it with the specific functional observations that justify it?
- Does this note show movement since the last period, or could it have been copied from it?
- If the patient hasn’t dropped a full PPS step, did I document the trend within the current score?
- Did I capture weight with a percentage and a time frame — and address whether edema or ascites might be masking true loss?
- Could a reviewer who has never met this patient see the decline from my words alone?
Where Hospice Intelligence Fits
This is the kind of detail that is easy to know at the bedside and easy to lose by the time the note is written after a long day of visits. Hospice Intelligence works alongside your existing EMR: you write your recertification note as you normally would, click Evaluate, and the system reads it against the full LCD criteria for the cancer diagnosis — showing you which criteria you captured and which ones you may have missed, each with a field to add detail if it applies to your patient. Every time it flags the PPS observations or the weight-and-fluid pairing you left out, you learn to look for them on the next visit, before you ever sit down to chart. It does not replace your clinical judgment; it helps you put what you already saw on the page, more completely and in about 20 minutes.
A note on the guidelines: Medicare LCD criteria are clinical guidelines, not pass/fail thresholds. No single PPS score or lab value determines eligibility on its own — the totality of the documented clinical picture, paired with sound clinical judgment, is what supports a defensible certification.
If this was helpful, follow along — I post Medicare compliance education every Wednesday. Have a question about documenting performance status in your cancer patients? Drop it in the comments — I read every one.
Want this kind of education in your inbox every week? Subscribe at hospiceintelligence.com.